Genezen's CEO discusses the current supply situation in viral vector manufacturing
- blonca9
- Oct 19, 2023
- 1 min read
Steve Favaloro explains why the industry is seeing shortages and what is being done by companies to boost supply.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.